🔬CDCs remodel organelles to trigger inflammation.
💡MedChemExpress offers the products featured in this study for research use only: #U0126, #Mirdametinib, #EGA, #Retro2cycl, #Pitstop2, and #Nigericin.
🔗 www.medchemexpress.com

#Immunology #BacterialToxins #CellBiology #Inflammation

Ezmekly becomes first approved EU therapy for NF1-PN in children and adults - PharmaTimes EC grants conditional marketing authorisation to Merck and SpringWorks Therapeutics

#Merck #SpringWorksTherapeutics #Ezmekly #mirdametinib #NF1PN #plexiformneurofibromas #neurofibromatosistype1 #NF1 #NF1PNpatients #NationalReferenceCenterforAdultPatientswithNeurofibromatosis #phase2bclinicaltrial #ReNeutrial #NFpatients #RareTumors
pharmatimes.com/news/ezmekly...

Just talked the my oncologist and I’m making the switch from #selumetinib to #mirdametinib

#nf1 #neurofibromatosis

FDA Approves Mirdametinib in Adult/Pediatric NF1-PN Findings from the phase 2b ReNeu trial support the approval of mirdametinib for patients with neurofibromatosis type 1-associated plexiform neurofibromas.

This offers a new hope for many patients and families.
Learn more: bit.ly/411tySo

Rare Cancers Program 2025 Coming Soon!

#NF1 #Neurofibromatosis #FDA #Mirdametinib #Gomekli #raredisease